Article Details
Retrieved on: 2021-02-24 22:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Debiopharm has developed several proprietary ADC technology platforms, Multilink™ a cleavable linker-drug -platform enabling high drug-to-antibody ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here